These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32913244)

  • 21. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections.
    Smolders D; Hendriks B; Rogiers P; Mul M; Gordts B
    J Hosp Infect; 2019 May; 102(1):82-88. PubMed ID: 30579969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae in Danish emergency departments - evaluation of national screening guidelines.
    Skjøt-Arkil H; Mogensen CB; Lassen AT; Johansen IS; Chen M; Petersen P; Andersen KV; Ellermann-Eriksen S; Møller JM; Ludwig M; Fuglsang-Damgaard D; Nielsen FE; Petersen DB; Jensen US; Rosenvinge FS
    J Hosp Infect; 2020 Jan; 104(1):27-32. PubMed ID: 31494129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of multi-pronged screening strategy to understand the epidemiology of carbapenemase-producing Enterobacteriaceae in Hong Kong: transition from epidemic to endemic setting.
    Wong SC; Chan VWM; Lam GK; AuYeung CH; Leung EY; So SY; Chen JH; Sridhar S; Tam AR; Hung IF; Ho PL; Yuen KY; Cheng VC
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):2017-2022. PubMed ID: 33666789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
    Fournier S; Lepainteur M; Kassis-Chikhani N; Huang M; Brun-Buisson C; Jarlier V;
    J Travel Med; 2012; 19(5):320-3. PubMed ID: 22943275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant
    Fournier S; Desenfant L; Monteil C; Nion-Huang M; Richard C; Jarlier V;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada
    Kohler PP; Melano RG; Patel SN; Shafinaz S; Faheem A; Coleman BL; Green K; Armstrong I; Almohri H; Borgia S; Borgundvaag E; Johnstone J; Katz K; Lam F; Muller MP; Powis J; Poutanen SM; Richardson D; Rebbapragada A; Sarabia A; Simor A; McGeer A;
    Emerg Infect Dis; 2018 Sep; 24(9):1674-1682. PubMed ID: 30124197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel's Long-term Care Facilities.
    Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ;
    Clin Infect Dis; 2019 Mar; 68(6):964-971. PubMed ID: 29986007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for carbapenemase-producing Enterobacteriaceae in previous carriers readmitted to hospital: evaluation of a change in screening policy.
    Tucker A; George R; Welfare W; Cleary P; Cawthorne J; Dodgson A
    J Hosp Infect; 2019 Oct; 103(2):156-159. PubMed ID: 31039383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.
    Wong D; Spellberg B
    Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
    Fedorowsky R; Peles-Bortz A; Masarwa S; Liberman D; Rubinovitch B; Lipkin V
    Am J Infect Control; 2015 Sep; 43(9):935-9. PubMed ID: 26116334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.
    Giannella M; Bartoletti M; Campoli C; Rinaldi M; Coladonato S; Pascale R; Tedeschi S; Ambretti S; Cristini F; Tumietto F; Siniscalchi A; Bertuzzo V; Morelli MC; Cescon M; Pinna AD; Lewis R; Viale P
    Clin Microbiol Infect; 2019 Dec; 25(12):1525-1531. PubMed ID: 31039445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunities lost may be the greatest cost of CPE outbreaks.
    Dunne CP; Slevin BL; Treacy P; O'Connell NH
    J Hosp Infect; 2019 Feb; 101(2):194-195. PubMed ID: 30359650
    [No Abstract]   [Full Text] [Related]  

  • 34. The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England.
    Donker T; Henderson KL; Hopkins KL; Dodgson AR; Thomas S; Crook DW; Peto TEA; Johnson AP; Woodford N; Walker AS; Robotham JV
    BMC Med; 2017 Apr; 15(1):86. PubMed ID: 28446169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.
    Enfield KB; Huq NN; Gosseling MF; Low DJ; Hazen KC; Toney DM; Slitt G; Zapata HJ; Cox HL; Lewis JD; Kundzins JR; Mathers AJ; Sifri CD
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):810-7. PubMed ID: 24915208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positivity of Carbapenemase-producing
    Park JJ; Seo YB; Lee J; Eom JS; Song W; Choi YK; Kim SR; Son HJ; Cho NH
    J Korean Med Sci; 2020 Sep; 35(36):e303. PubMed ID: 32924341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging extensively drug-resistant bacteria (eXDR) in France in 2018.
    Colomb-Cotinat M; Soing-Altrach S; Leon A; Savitch Y; Poujol I; Naas T; Cattoir V; Berger-Carbonne A; Dortet L;
    Med Mal Infect; 2020 Nov; 50(8):715-722. PubMed ID: 32113869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
    Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
    Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.